NASDAQUTHR

aluxum United Therapeutics (NASDAQ:UTHR) traded lower on Thursday after Morgan Stanley downgraded the Tyvaso maker to Equal Weight from Overweight, citing a balanced risk-reward setup following strong gains this year. Morgan Stanley said that United Therapeutics (UTHR), which markets drugs for a lung disorder called pulmonary arterial hypertension (PAH), hasContinue Reading